Literature DB >> 15699397

Primary progressive aphasia: reversed asymmetry of atrophy and right hemisphere language dominance.

M Mesulam1, S Weintraub, T Parrish, D Gitelman.   

Abstract

Primary progressive aphasia (PPA) is almost always associated with asymmetrical left hemisphere degeneration. The authors report that right hemisphere atrophy in a patient with PPA was associated with atypical right hemisphere dominance for language. This suggests that neuronal damage in PPA is therefore tightly linked to the underlying anatomy of the language network.

Entities:  

Mesh：

Year:  2005        PMID： 15699397     DOI： 10.1212/01.WNL.0000150545.46351.DE

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  17 in total

1.  Asymmetric TDP pathology in primary progressive aphasia with right hemisphere language dominance.

Authors:  Garam Kim; Shahrooz Vahedi; Tamar Gefen; Sandra Weintraub; Eileen H Bigio; Marek-Marsel Mesulam; Changiz Geula
Journal:  Neurology       Date:  2018-01-05       Impact factor: 9.910

2.  Anomalous functional language lateralization in semantic variant PPA.

Authors:  Zachary A Miller; Leighton B Hinkley; Alex Herman; Susanne Honma; Anne Findlay; Nikolas Block; Robin Ketelle; Gil Rabinovici; Howard Rosen; Srikantan S Nagarajan; Bruce L Miller; Maria Luisa Gorno-Tempini
Journal:  Neurology       Date:  2014-12-03       Impact factor: 9.910

3.  Nonfluent Variant of Primary Progressive Aphasia With Right Hemisphere Atrophy - A Phenotype of Corticobasal Degeneration?

Authors:  Jos S Becktepe; Jan Sedlacik; Holger Jahn; Kai Boelmans
Journal:  Mov Disord Clin Pract       Date:  2015-06-30

4.  Perturbations of language network connectivity in primary progressive aphasia.

Authors:  Borna Bonakdarpour; Robert S Hurley; Allan R Wang; Hernando R Fereira; Anisha Basu; Arjuna Chatrathi; Kyla Guillaume; Emily J Rogalski; M Marsel Mesulam
Journal:  Cortex       Date:  2019-09-09       Impact factor: 4.027

5.  Primary Progressive Aphasia has a Unique Signature Distinct from Dementia of the Alzheimer's Type and Behavioral Variant Frontotemporal Dementia Regardless of Pathology.

Authors:  Tamar Gefen; Qinwen Mao; Missia Kohler; Stacey Moeller; Allegra Kawles; Christina Coventry; Callen Spencer; Jaclyn Lilek; Kaouther Ajroud; Alex Feldman; Margaret Flanagan; Emily Rogalski; Sandra Weintraub; Alfred Rademaker; Changiz Geula; M-Marsel Mesulam; Eileen Bigio
Journal:  J Neuropathol Exp Neurol       Date:  2020-12-04       Impact factor: 3.685

6.  Prominent microglial activation in cortical white matter is selectively associated with cortical atrophy in primary progressive aphasia.

Authors:  D T Ohm; G Kim; T Gefen; A Rademaker; S Weintraub; E H Bigio; M-M Mesulam; E Rogalski; C Geula
Journal:  Neuropathol Appl Neurobiol       Date:  2018-05-17       Impact factor: 8.090

7.  Atrophy and microglial distribution in primary progressive aphasia with transactive response DNA-binding protein-43 kDa.

Authors:  Garam Kim; Kabriya Bolbolan; Tamar Gefen; Sandra Weintraub; Eileen H Bigio; Emily Rogalski; Marek-Marsel Mesulam; Changiz Geula
Journal:  Ann Neurol       Date:  2018-05-24       Impact factor: 10.422

8.  Verbal creativity in semantic variant primary progressive aphasia.

Authors:  Teresa Q Wu; Zachary A Miller; Babu Adhimoolam; Diana D Zackey; Baber K Khan; Robin Ketelle; Katherine P Rankin; Bruce L Miller
Journal:  Neurocase       Date:  2013-12-12       Impact factor: 0.881

9.  Asymmetry and heterogeneity of Alzheimer's and frontotemporal pathology in primary progressive aphasia.

Authors:  M-Marsel Mesulam; Sandra Weintraub; Emily J Rogalski; Christina Wieneke; Changiz Geula; Eileen H Bigio
Journal:  Brain       Date:  2014-02-25       Impact factor: 13.501

Review 10.  Primary progressive aphasia and the evolving neurology of the language network.

Authors:  M-Marsel Mesulam; Emily J Rogalski; Christina Wieneke; Robert S Hurley; Changiz Geula; Eileen H Bigio; Cynthia K Thompson; Sandra Weintraub
Journal:  Nat Rev Neurol       Date:  2014-09-02       Impact factor: 42.937
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.